to review documents for attorney/client privilege. is this sort of telling us what they re finding now? exactly. this is the status report of what that team this team, this filter team, that s what they re called, was involved with from the beginning when the search warrant was executed at mar-a-lago. former president trump s lawyers want a special master, an independent person to conduct the review. the judge told doj tell us what you ve done so far, it s been three weeks since you ve had these documents. that s what the new filing says, it s identified a limited set of materials that could possibly be covered by attorney/client privilege. they said they completed this review and have begun the process of going over anything where there could be a dispute. the search warrant lays out different ways that they were planning to handle a dispute, possibly going to the judge in private and saying, judge, do you think this could be covered by attorney/client privilege? setting
advisor, expressed concerns about using the flu shot comparison. when we look at this, though, two-part question. one, based on what you know so far, does it appear that this booster, which is specifically targeting omicron, is going to be effective? well, that s the big question, right? and likely yes, but you d certainly like to have some human data, something beyond mouse data to justify that. the thing is ba.5 is starting to go down now, and i think the thinking from the fda is that if we re going to immunize against ba.5, now is the time to do it. also as we move later into the fall, if we have a new variant of concern, it might look more like ba.5 than it does the original lineages, there s still a lot of question marks about that. are you concerned at all that the knowledge that this booster could be given the green light without that human clinical trial data? are you concerned at all about how that could feed and fuel vaccine skeptics? yeah.
i think they re basing it on what we do with influenza vaccines which is we have a lot of experience with the technology and so each new flu strain, each new flu vaccine is tailor made to the variants that are around at this time, and thinking that we have enough experience over decades to administer on a yearly basis without doing additional human testing. i understand that. my issue with mrna vaccines is still relatively new. we don t nearly have that wealth of experience. so i agree we absolutely need boosters, adults over the age of 50 will eventually need third boosters, we need fifth immunizations. those under 50 will need second immunizations as boosters. the question is whether we move forward with the original lineage or pair those together. that will be under discussion at the acip meeting at the cdc. yeah. and dr. paul affett on the fda